Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2015
December 2015, Vol 6, No 11
December 2015, Vol 6, No 11
Urine Biopsies Detect Early Mutations in Patients with Advanced Cancers
By
Wayne Kuznar
Personalized Medicine
December 2015, Vol 6, No 11
An assay that measures circulating tumor (ct) DNA in the urine can detect mutations in patients with a variety of advanced cancers, according to a recent study.
Read Article
Personalized Medicine a Vital Aspect of Palliative Care
By
Meg Barbor, MPH
Palliative Care
,
Personalized Medicine
December 2015, Vol 6, No 11
Boston, MA—Delivering the keynote lecture at the 2015 Palliative Care in Oncology Symposium, Howard L. McLeod, PharmD, Medical Director of the DeBartolo Family Personalized Medicine Institute at Moffitt Cancer Center, Tampa, FL, discussed advances in personalized medicine as they relate to palliative care, as well as the continuing challenges in cancer care.
Read Article
ASCO/AAHPM Guidance Statement Could Standardize Palliative Care in Oncology
By
Meg Barbor, MPH
Clinical Guidelines
,
Palliative Care
,
Policies & Guidelines
December 2015, Vol 6, No 11
Boston, MA—A new guidance statement from the American Society of Clinical Oncology (ASCO) and the American Academy of Hospice and Palliative Medicine (AAHPM) provides the first formal, consensus-based recommendations regarding high-quality primary palliative care in oncology, according to Kathleen E. Bickel, MD, MPhil, Assistant Professor of Medicine, Geisel School of Medicine at Dartmouth, Hanover, NH.
Read Article
Oncology News - December 2015
Oncology News
December 2015, Vol 6, No 11
Read Article
Oncology Medical Home Shows Significant Cost-Savings, Improved Care Delivery
By
Wayne Kuznar
Oncology Practice
December 2015, Vol 6, No 11
Washington, DC—The COME HOME initiative, a 7-member oncology medical home practice partnership, has documented significant reductions in hospitalization rates, inpatient days, and total cost of care of approximately $5 million over a 6-month period, said Barbara L. McAneny, MD, at the Fifth Annual Conference of the Association for Value-Based Cancer Care.
Read Article
Genomic Test Supports Treatment Decisions in Prostate Cancer
By
Phoebe Starr
Personalized Medicine
,
Prostate Cancer
,
Solid Tumors
December 2015, Vol 6, No 11
San Antonio, TX—A genomic classifier is now available that can predict a low or high risk for metastasis in men with prostate cancer who have rising prostate-specific antigen (PSA) after a prostatectomy. The good news is that this test is reimbursable by Medicare.
Read Article
Family Patient-Related Factors Main Barriers to End-of-Life Discussions
By
Meg Barbor, MPH
End-of-Life Care
,
Palliative Care
,
Policies & Guidelines
December 2015, Vol 6, No 11
Boston, MA—Family- and patient-related factors were identified as the most significant barriers to early end-of-life discussions, as well as to the timely discontinuation of cancer-directed therapies in the palliative setting, according to the results of a multicenter survey of oncologists in Ontario, Canada.
Read Article
American Cancer Society Updates Breast Cancer Screening Guidelines for Women at Average Risk
By
Laura Morgan
Breast Cancer
,
Solid Tumors
December 2015, Vol 6, No 11
Breast cancer is the leading cause of premature death in women. According to the American Cancer Society (ACS), more than 40,000 US women will die of breast cancer in 2015.
Read Article
Page 2 of 2
1
2
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma